HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

72 hedge funds and large institutions have $74.1M invested in Harvard Bioscience in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 13 closing their positions.

Holders
72
Holders Change
-2
Holders Change %
-2.7%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
21
Reduced
24
Closed
13
Calls
$150K
Puts
–
Net Calls
+$150K
Net Calls Change
-$7K

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$3.56M
2
HA
2
Heartland Advisors
Wisconsin
$1.23M
3
BG
3
BlackRock Group
United Kingdom
$1.03M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$4.1M
5
WCM
5
Wedge Capital Management
North Carolina
$580K

Top Sellers

1
GPC
1
Glacier Peak Capital
Washington
$0
2
Northern Trust
2
Northern Trust
Illinois
$315K
3
Deutsche Bank
3
Deutsche Bank
Germany
$0
4
PP
4
Paloma Partners
Connecticut
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
76
Bank of America
North Carolina
– -$293K -64,386 Closed
CS
77
Credit Suisse
Switzerland
– -$260K -57,117 Closed
CSM
78
Central Square Management
Illinois
– -$123K -26,981 Closed
CCA
79
Catalyst Capital Advisors
New York
– -$105K -22,981 Closed
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
– -$64K -14,128 Closed
GC
81
Guggenheim Capital
Illinois
– -$57K -12,451 Closed
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
– -$2.23K -491 Closed
TA
83
Teachers Advisors
New York
– -$1K -290 Closed
1 2 3
4